Price (90d)
No price history yet — the daily price refresh runs once a day.
Signal Score (90d)
100Quote
Valuation & Ratios
Returns & Efficiency
Revenue & Net Income (Annual)
| Fiscal Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2023 | $139.91M | $-140.75M | $-2.23 |
| 2022 | $149.27M | $560.0K | $0.01 |
| 2021 | $119.60M | $127.67M | $2.08 |
| 2020 | $95.87M | $11.21M | $0.06 |
| 2019 | $59.70M | $-7.26M | $-0.13 |
Social Signal Score
Earnings
Typical surprise -108.5% (median, so one quarter with a near-zero estimate can't distort it)
- Tue, Dec 10$-0.27 vs $-0.12miss
- Mon, Sep 9$-0.09 vs $-0.04miss
- Tue, Jul 2$-1.94 vs $-0.04miss
- Wed, Apr 24$-0.08 vs $-0.02miss
- Thu, Dec 7$-0.12 vs $-0.06miss
- Thu, Sep 7$-0.03 vs $-0.03beat
Estimates and results for CDMO via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.
Valuation
CDMOhas no positive reported earnings per share, so an earnings-multiple projection can't be built for it. Companies are valued on other measures at this stage — revenue growth, cash burn, or book value — none of which this calculator models.
Mentions (1)
- Newsprnewswire.com·5d ago·Neutral
Scinai Strengthens CDMO Leadership with Appointment of Eran Kuratz as Head of Supply Chain and Business Process Administration Appointment strengthens operational infrastructure and supports integration and scale-up of Scinai's expanded CDMO platform. JERUSALEM, Aug. 10, 2026 /PRNewswire/ -- Scinai Immunotherapeutics Ltd.
View source ↗